Related Experiment Video
Updated: Jun 23, 2026

Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
CHRONIC ACTINOMYCES NEUII ENDOPHTHALMITIS POSTCATARACT SURGERY TREATED WITH INTRAVENOUS AND INTRAMUSCULAR ANTIBIOTICS
Carol Tadrous1, Nadine Cheffi2,3, Rishi B Gupta2
1Department of Ophthalmology, University of British Columbia, Vancouver, BC, Canada.
Purpose:
To report a case of recalcitrant Actinomyces neuii ( A. neuii ) chronic postoperative endophthalmitis successfully treated with prolonged systemic penicillin therapy and intraocular lens explantation, with pharmacokinetic confirmation of therapeutic intravitreal drug levels.
Methods:
Retrospective case report with focused literature review.
Results:
A 77-year-old man developed recurrent anterior uveitis and cystoid macular edema after uncomplicated cataract surgery. Vitreous cultures grew A. neuii . Despite repeated intravitreal antibiotics and vitrectomies, inflammation recurred over several years. After infectious disease consultation, IV penicillin G (4 million units every 4 hours for 4 weeks) was administered, followed by intramuscular benzathine penicillin G (2.4 million units every 2 weeks for 6 months), in conjunction with intraocular lens explantation. Intravitreal sampling 4 hours after IV dosing demonstrated penicillin G concentration of 3.5 µ g/mL, exceeding published minimum inhibitory concentrations for Actinomyces species . Inflammation remained quiescent at long-term follow-up with VA limited because of secondary complications from chronic macular edema.
Conclusion:
This case highlights the importance of systemic therapy and interdisciplinary management in recalcitrant chronic postoperative endophthalmitis caused by unusual pathogens. Our approach, including prolonged IV and intramuscular antibiotic courses with confirmed therapeutic intraocular concentrations and intraocular lens removal, proved effective for sustained resolution.
Insights
Recalcitrant Actinomyces neuii chronic postoperative endophthalmitis (CPE) requires prolonged systemic penicillin and intraocular lens (IOL) explantation. Pharmacokinetic confirmation of intravitreal drug levels supports this successful treatment approach for sustained resolution.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Chronic postoperative endophthalmitis (CPE) can be challenging to treat.
- Actinomyces neuii is an unusual pathogen causing CPE.
- Recalcitrant cases necessitate exploring alternative therapeutic strategies.
Purpose of the Study:
- To report a successful treatment of recalcitrant Actinomyces neuii CPE.
- To demonstrate the efficacy of prolonged systemic penicillin therapy.
- To confirm therapeutic intravitreal drug levels via pharmacokinetic analysis.
Main Methods:
- Retrospective case report.
- Focused literature review.
- Intravenous and intramuscular penicillin G administration.
- Intraocular lens (IOL) explantation.
- Pharmacokinetic analysis of intravitreal penicillin G levels.
Main Results:
- A 77-year-old male with recurrent CPE due to A. neuii showed sustained resolution.
- Treatment involved prolonged systemic penicillin G and IOL explantation.
- Achieved therapeutic intravitreal penicillin G concentrations (3.5 μg/mL).
- Visual acuity was limited by prior macular edema complications.
Conclusions:
- Systemic therapy and interdisciplinary management are crucial for recalcitrant CPE.
- Prolonged antibiotic courses with confirmed intraocular concentrations and IOL removal are effective.
- This approach offers sustained resolution for complex endophthalmitis cases.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Microbiome of the Eye
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

